3.3819
price down icon3.37%   -0.1181
after-market 시간 외 거래: 3.54 0.1581 +4.67%
loading
전일 마감가:
$3.50
열려 있는:
$3.5681
하루 거래량:
31,870
Relative Volume:
2.23
시가총액:
$372.13M
수익:
$16.82M
순이익/손실:
$-112.19M
주가수익비율:
-1.5245
EPS:
-2.2183
순현금흐름:
$-91.84M
1주 성능:
-13.06%
1개월 성능:
+9.09%
6개월 성능:
+22.98%
1년 성능:
+5.68%
1일 변동 폭
Value
$3.30
$3.7307
1주일 범위
Value
$3.30
$3.89
52주 변동 폭
Value
$1.53
$4.05

인벤티바 Stock (IVA) Company Profile

Name
명칭
Inventiva Adr
Name
전화
-
Name
주소
-
Name
직원
118
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
IVA's Discussions on Twitter

IVA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IVA
Inventiva Adr
3.3819 372.13M 16.82M -112.19M -91.84M -2.2183
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

인벤티바 Stock (IVA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-21 개시 TD Cowen Buy
2024-11-12 개시 UBS Neutral
2023-10-27 개시 Canaccord Genuity Buy
2023-05-31 개시 ROTH MKM Buy
2023-05-19 업그레이드 Societe Generale Sell → Buy
2023-03-17 개시 Stifel Buy
2022-11-15 다운그레이드 Societe Generale Buy → Sell
2021-03-08 다운그레이드 Societe Generale Buy → Sell
2020-08-05 개시 ROTH Capital Buy
2020-08-04 개시 Guggenheim Buy
2020-08-04 개시 Stifel Buy
모두보기

인벤티바 주식(IVA)의 최신 뉴스

pulisher
Apr 04, 2025

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 04, 2025
pulisher
Apr 02, 2025

Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Stifel maintains Buy on Inventiva shares with $17 target - Investing.com

Apr 02, 2025
pulisher
Apr 01, 2025

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée - GlobeNewswire Inc.

Apr 01, 2025
pulisher
Mar 28, 2025

Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 28, 2025
pulisher
Mar 26, 2025

Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com

Mar 26, 2025
pulisher
Jan 30, 2025

Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva

Jan 30, 2025
pulisher
Oct 24, 2024

Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Oct 24, 2024
pulisher
Oct 14, 2024

Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com

Oct 14, 2024
pulisher
Aug 28, 2024

Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - inventiva.co.in

Aug 28, 2024
pulisher
Jun 18, 2024

Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Nasdaq

Jun 18, 2024
pulisher
Apr 24, 2024

NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - inventiva.co.in

Apr 24, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Oct 10, 2023

Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva

Oct 10, 2023
pulisher
Mar 06, 2023

Top 10 Best Handicraft Companies In USA 2023 - inventiva.co.in

Mar 06, 2023
pulisher
Feb 22, 2023

Top 20 Best Hardware & Networking Company In India 2023 - Inventiva

Feb 22, 2023
pulisher
Oct 03, 2021

Inventiva SaAdr Share Price Today (NASDAQ: IVA)Inventiva SaAdr Stock Price Live Quote - INDmoney

Oct 03, 2021
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021
pulisher
Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020

인벤티바 (IVA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
자본화:     |  볼륨(24시간):